Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

HBED-NN: A Bifunctional Chelator for Constructing Radiopharmaceuticals.

Makarem A, Klika KD, Litau G, Remde Y, Kopka K.

J Org Chem. 2019 Jun 7;84(11):7501-7508. doi: 10.1021/acs.joc.9b00832. Epub 2019 May 15.

PMID:
31064181
2.

Designing tracers for PET imaging of the urokinase-type plasminogen activator receptor from a cyclic uPA-derived peptide: first in vitro evaluations.

Wacker A, Bauder-Wüst U, Schäfer M, Schmidt J, Remde Y, Stadlbauer S, Eder M, Liolios C, Kopka K.

J Labelled Comp Radiopharm. 2019 Jun 30;62(8):483-494. doi: 10.1002/jlcr.3735. Epub 2019 Jun 6.

PMID:
30970388
3.

Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer.

Cardinale J, Martin R, Remde Y, Schäfer M, Hienzsch A, Hübner S, Zerges AM, Marx H, Hesse R, Weber K, Smits R, Hoepping A, Müller M, Neels OC, Kopka K.

Pharmaceuticals (Basel). 2017 Sep 27;10(4). pii: E77. doi: 10.3390/ph10040077.

4.

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer.

Eder M, Neels O, Müller M, Bauder-Wüst U, Remde Y, Schäfer M, Hennrich U, Eisenhut M, Afshar-Oromieh A, Haberkorn U, Kopka K.

Pharmaceuticals (Basel). 2014 Jun 30;7(7):779-96. doi: 10.3390/ph7070779.

Supplemental Content

Loading ...
Support Center